F. Repetto, “Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study”, Acta Derm Venereol, vol. 103, p. adv5278, Apr. 2023.